<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01091948</url>
  </required_header>
  <id_info>
    <org_study_id>08-079</org_study_id>
    <nct_id>NCT01091948</nct_id>
  </id_info>
  <brief_title>GlideScope Video Laryngoscope Versus Fiberoptic Intubation</brief_title>
  <official_title>GlideScope Video Laryngoscope vs Fiberoptic Intubation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Cleveland Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Cleveland Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Following informed consent, patients will be randomly assigned to oral fiberoptic intubation
      or to oral intubation using the GlideScope Video Laryngoscope. Following the induction of
      general anesthesia a sealed envelope would be opened to reveal the technique to be used. A
      stop watch will be started at the beginning of the procedure. At the completion of intubation
      the stop watch will be stopped and the time recorded along with other data. Based on a sample
      size estimation process, it is the investigators plan to study fifty patients. The two
      techniques will be compared in terms of the average time needed to place the endotracheal
      tube and studied using a two-sided T-Test with a significance level of 0.05. To ensure
      comparability between the two methods, all intubators will be required to have at experienced
      at least 10 uses of the GlideScope and 10 uses with fiberoptic intubation.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2008</start_date>
  <completion_date type="Actual">January 2010</completion_date>
  <primary_completion_date type="Actual">June 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to Intubation (TTI) as Measured in Seconds</measure>
    <time_frame>from start of intubation to successfully intubated up to 100 seconds</time_frame>
    <description>Time from insertion of either the GlideScope or in the case of fibreoptic intubation, a Williams airway (SunMed, Largo, FL, USA) into the mouth, to the time when end-tidal PCO2 exceeded 2.7 kPa (20 mmHg).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intubation Difficulty Score</measure>
    <time_frame>from start of intubation to successfully intubated</time_frame>
    <description>Intubation difficulty score is a 100-mm-long visual analogue scale (100 mm = extremely difficult);</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Successful Intubation on 1st Attempt</measure>
    <time_frame>from start of first intubation to end of first intubation attempt</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurrence of Hypoxaemia</measure>
    <time_frame>at 1 min prior to intubation, intubation, and 2, 4, 6, 8, and 10 min after</time_frame>
    <description>Arterial oxygen saturation was recorded at 1 min prior to intubation, intubation, and 2, 4, 6, 8, and 10 min after; hypoxaemia was defined as occurrence of arterial oxygen saturation &lt;90% at any of the above measurements.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Trace Bleeding</measure>
    <time_frame>Right after intubation</time_frame>
    <description>Trace bleeding is a binary outcome: yes or no, which is determined based on amount of post-intubation bleeding present in the suction tube</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sore Throat Grade</measure>
    <time_frame>On the first postoperative day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Intubation Attempts</measure>
    <time_frame>from start of intubation to successfully intubated</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">75</enrollment>
  <condition>Oral Intubation</condition>
  <arm_group>
    <arm_group_label>Fiberoptic Intubation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects will be intubated with the Fiberoptic laryngoscope.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>GlideScope® Video Laryngoscope</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects will be intubated with the GlideScope® Video Laryngoscope.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Intubation with Fiberoptic laryngoscope</intervention_name>
    <description>Subjects will be intubated with the Fiberoptic laryngoscope.</description>
    <arm_group_label>Fiberoptic Intubation</arm_group_label>
    <other_name>Fiberoptic</other_name>
    <other_name>laryngoscope</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>GlideScope® Video Laryngoscope</intervention_name>
    <description>Patients will be intubated with the GlideScope® Video Laryngoscope.</description>
    <arm_group_label>GlideScope® Video Laryngoscope</arm_group_label>
    <other_name>GlideScope®</other_name>
    <other_name>Video Laryngoscope</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  at least 18 years old

          -  scheduled for elective surgery requiring orotracheal intubation.

        Exclusion Criteria:

          -  known, difficult airway

          -  loose teeth

          -  pregnant

          -  require a rapid sequence induction,

          -  Body Mass Index under 30

          -  unable to give consent

          -  if special endotracheal tube (ETT) is needed for the case.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daniel I Sessler, MD</last_name>
    <role>Study Chair</role>
    <affiliation>The Cleveland Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cleveland Clinic Foundation</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 9, 2010</study_first_submitted>
  <study_first_submitted_qc>March 23, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 24, 2010</study_first_posted>
  <results_first_submitted>June 20, 2016</results_first_submitted>
  <results_first_submitted_qc>October 26, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">December 20, 2016</results_first_posted>
  <last_update_submitted>October 26, 2016</last_update_submitted>
  <last_update_submitted_qc>October 26, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 20, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>elective general surgery</keyword>
  <keyword>orotracheal intubation</keyword>
  <keyword>Patients would be eligible for inclusion if they were at least 18 years old and scheduled for elective surgery requiring orotracheal intubation.</keyword>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Active Comparator: Fiberoptic Intubation</title>
          <description>Subjects will be intubated with the Fiberoptic laryngoscope.
Active Comparator: GlideScope® Video Laryngoscope Subjects will be intubated with the GlideScope® Video Laryngoscope</description>
        </group>
        <group group_id="P2">
          <title>GlideScope® Video Laryngoscope</title>
          <description>Subjects will be intubated with the GlideScope® Video Laryngoscope.
GlideScope® Video Laryngoscope: Patients will be intubated with the GlideScope® Video Laryngoscope.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="37"/>
                <participants group_id="P2" count="38"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="37"/>
                <participants group_id="P2" count="38"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Fiberoptic Intubation</title>
          <description>Subjects will be intubated with the Fiberoptic laryngoscope.
Intubation with Fiberoptic laryngoscope: Subjects will be intubated with the Fiberoptic laryngoscope.</description>
        </group>
        <group group_id="B2">
          <title>GlideScope® Video Laryngoscope</title>
          <description>Subjects will be intubated with the GlideScope® Video Laryngoscope.
GlideScope® Video Laryngoscope: Patients will be intubated with the GlideScope® Video Laryngoscope.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="37"/>
            <count group_id="B2" value="38"/>
            <count group_id="B3" value="75"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="54" spread="11"/>
                    <measurement group_id="B2" value="52" spread="16"/>
                    <measurement group_id="B3" value="53" spread="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="26"/>
                    <measurement group_id="B3" value="44"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Caucasian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="36"/>
                    <measurement group_id="B2" value="33"/>
                    <measurement group_id="B3" value="69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Others</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="37"/>
                    <measurement group_id="B2" value="38"/>
                    <measurement group_id="B3" value="75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Weight</title>
          <units>Kg</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="117" lower_limit="95" upper_limit="141"/>
                    <measurement group_id="B2" value="104" lower_limit="93" upper_limit="117"/>
                    <measurement group_id="B3" value="110" lower_limit="93" upper_limit="126"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Height</title>
          <units>cm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="171" spread="12"/>
                    <measurement group_id="B2" value="167" spread="10"/>
                    <measurement group_id="B3" value="169" spread="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body mass index</title>
          <units>kg/m^2</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="37" lower_limit="33" upper_limit="49"/>
                    <measurement group_id="B2" value="36" lower_limit="34" upper_limit="44"/>
                    <measurement group_id="B3" value="37" lower_limit="33" upper_limit="46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>ASA physical status</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>I: A normal healthy patient</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>II: A patient with mild systemic disease</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>III: A patient with severe systemic disease</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Modified Mallampati classification</title>
          <description>Modified Mallampati classification was not collected for one patient in the GlideScope Video Laryngoscope group.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>I: Soft palate, uvula, fauces, pillars visible.</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>II: Soft palate, uvula, fauces visible.</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="19"/>
                    <measurement group_id="B3" value="38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>III: Soft palate, base of uvula visible.</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IV: Only hard palate visible.</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Time to Intubation (TTI) as Measured in Seconds</title>
        <description>Time from insertion of either the GlideScope or in the case of fibreoptic intubation, a Williams airway (SunMed, Largo, FL, USA) into the mouth, to the time when end-tidal PCO2 exceeded 2.7 kPa (20 mmHg).</description>
        <time_frame>from start of intubation to successfully intubated up to 100 seconds</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Active Comparator: Fiberoptic Intubation</title>
            <description>Subjects will be intubated with the Fiberoptic laryngoscope.</description>
          </group>
          <group group_id="O2">
            <title>GlideScope® Video Laryngoscope</title>
            <description>Patients will be intubated with the GlideScope® Video Laryngoscope.</description>
          </group>
        </group_list>
        <measure>
          <title>Time to Intubation (TTI) as Measured in Seconds</title>
          <description>Time from insertion of either the GlideScope or in the case of fibreoptic intubation, a Williams airway (SunMed, Largo, FL, USA) into the mouth, to the time when end-tidal PCO2 exceeded 2.7 kPa (20 mmHg).</description>
          <units>seconds</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="38"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43" lower_limit="35" upper_limit="58"/>
                    <measurement group_id="O2" value="37" lower_limit="25" upper_limit="48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.19</p_value>
            <method>Regression, Cox</method>
            <method_desc>Intubations accomplished with another device due to difficulty with assigned device and those took &gt;180 s were considered as failed intubations.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Intubation Difficulty Score</title>
        <description>Intubation difficulty score is a 100-mm-long visual analogue scale (100 mm = extremely difficult);</description>
        <time_frame>from start of intubation to successfully intubated</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Fiberoptic Intubation</title>
            <description>Subjects will be intubated with the Fiberoptic laryngoscope.</description>
          </group>
          <group group_id="O2">
            <title>GlideScope® Video Laryngoscope</title>
            <description>Patients will be intubated with the GlideScope® Video Laryngoscope.</description>
          </group>
        </group_list>
        <measure>
          <title>Intubation Difficulty Score</title>
          <description>Intubation difficulty score is a 100-mm-long visual analogue scale (100 mm = extremely difficult);</description>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="38"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20" lower_limit="11" upper_limit="40"/>
                    <measurement group_id="O2" value="15" lower_limit="10" upper_limit="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.58</p_value>
            <method>ANCOVA</method>
            <param_type>Ratio of Geometric Means</param_type>
            <param_value>0.89</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.58</ci_lower_limit>
            <ci_upper_limit>1.35</ci_upper_limit>
            <estimate_desc>The mean intubation difficulty score was tested after logarithmic transformation, and then back transformed for the estimated treatment effect.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Successful Intubation on 1st Attempt</title>
        <time_frame>from start of first intubation to end of first intubation attempt</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Fiberoptic Intubation</title>
            <description>Subjects will be intubated with the Fiberoptic laryngoscope.</description>
          </group>
          <group group_id="O2">
            <title>GlideScope® Video Laryngoscope</title>
            <description>Patients will be intubated with the GlideScope® Video Laryngoscope.</description>
          </group>
        </group_list>
        <measure>
          <title>Successful Intubation on 1st Attempt</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="38"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31"/>
                    <measurement group_id="O2" value="36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.15</p_value>
            <method>Cochran-Mantel-Haenszel</method>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>1.13</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.95</ci_lower_limit>
            <ci_upper_limit>1.33</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Occurrence of Hypoxaemia</title>
        <description>Arterial oxygen saturation was recorded at 1 min prior to intubation, intubation, and 2, 4, 6, 8, and 10 min after; hypoxaemia was defined as occurrence of arterial oxygen saturation &lt;90% at any of the above measurements.</description>
        <time_frame>at 1 min prior to intubation, intubation, and 2, 4, 6, 8, and 10 min after</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Fiberoptic Intubation</title>
            <description>Subjects will be intubated with the Fiberoptic laryngoscope.</description>
          </group>
          <group group_id="O2">
            <title>GlideScope® Video Laryngoscope</title>
            <description>Patients will be intubated with the GlideScope® Video Laryngoscope.</description>
          </group>
        </group_list>
        <measure>
          <title>Occurrence of Hypoxaemia</title>
          <description>Arterial oxygen saturation was recorded at 1 min prior to intubation, intubation, and 2, 4, 6, 8, and 10 min after; hypoxaemia was defined as occurrence of arterial oxygen saturation &lt;90% at any of the above measurements.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="38"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.57</p_value>
            <method>Cochran-Mantel-Haenszel</method>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>1.67</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.28</ci_lower_limit>
            <ci_upper_limit>10.2</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Trace Bleeding</title>
        <description>Trace bleeding is a binary outcome: yes or no, which is determined based on amount of post-intubation bleeding present in the suction tube</description>
        <time_frame>Right after intubation</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Fiberoptic Intubation</title>
            <description>Subjects will be intubated with the Fiberoptic laryngoscope.</description>
          </group>
          <group group_id="O2">
            <title>GlideScope® Video Laryngoscope</title>
            <description>Patients will be intubated with the GlideScope® Video Laryngoscope.</description>
          </group>
        </group_list>
        <measure>
          <title>Trace Bleeding</title>
          <description>Trace bleeding is a binary outcome: yes or no, which is determined based on amount of post-intubation bleeding present in the suction tube</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="38"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.79</p_value>
            <method>Cochran-Mantel-Haenszel</method>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>1.01</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.93</ci_lower_limit>
            <ci_upper_limit>1.09</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Sore Throat Grade</title>
        <time_frame>On the first postoperative day</time_frame>
        <population>This outcome was not collected for 1 patient in each group.</population>
        <group_list>
          <group group_id="O1">
            <title>Fiberoptic Intubation</title>
            <description>Subjects will be intubated with the Fiberoptic laryngoscope.</description>
          </group>
          <group group_id="O2">
            <title>GlideScope® Video Laryngoscope</title>
            <description>Patients will be intubated with the GlideScope® Video Laryngoscope.</description>
          </group>
        </group_list>
        <measure>
          <title>Sore Throat Grade</title>
          <population>This outcome was not collected for 1 patient in each group.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="36"/>
                <count group_id="O2" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>None</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19"/>
                    <measurement group_id="O2" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.82</p_value>
            <method>Regression, Logistic</method>
            <method_desc>proportional odds logistic regression model</method_desc>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>1.11</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.45</ci_lower_limit>
            <ci_upper_limit>2.76</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Intubation Attempts</title>
        <time_frame>from start of intubation to successfully intubated</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Fiberoptic Intubation</title>
            <description>Subjects will be intubated with the Fiberoptic laryngoscope.</description>
          </group>
          <group group_id="O2">
            <title>GlideScope® Video Laryngoscope</title>
            <description>Patients will be intubated with the GlideScope® Video Laryngoscope.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Intubation Attempts</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="38"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31"/>
                    <measurement group_id="O2" value="36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Fiberoptic</title>
          <description>Subjects will be intubated with the Fiberoptic laryngoscope.</description>
        </group>
        <group group_id="E2">
          <title>GlideScope® Video Laryngoscope</title>
          <description>Subjects will be intubated with the GlideScope® Video Laryngoscope</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="37"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="38"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="37"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="38"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Basem Abdelmalak</name_or_title>
      <organization>Cleveland Clinic Foundation</organization>
      <phone>216-444-3746</phone>
      <email>abdelmb@ccf.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

